These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients. O'Shea D; Giles C; Terpos E; Perz J; Politou M; Sana V; Naresh K; Lampert I; Samson D; Narat S; Kanfer E; Olavarria E; Apperley JF; Rahemtulla A Bone Marrow Transplant; 2006 Apr; 37(8):731-7. PubMed ID: 16501593 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of patients diagnosed with psoriasis and multiple myeloma after autologous stem cell transplantation. Ugur MC; Gediz F Transfus Apher Sci; 2021 Aug; 60(4):103137. PubMed ID: 33858753 [TBL] [Abstract][Full Text] [Related]
8. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple Myeloma. Harousseau JL; Attal M; Divine M; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M; Abgrall JF Stem Cells; 1995 Aug; 13 Suppl 2():132-9. PubMed ID: 8520502 [TBL] [Abstract][Full Text] [Related]
9. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation. Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH; Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634 [TBL] [Abstract][Full Text] [Related]
10. Lymphocyte recovery: an overlooked contribution to autologous stem cell transplant outcome. Le Blanc K Cytotherapy; 2008; 10(5):441-2. PubMed ID: 18622799 [No Abstract] [Full Text] [Related]
11. [Single vs double stem cell transplantation for the treatment of multiple myeloma]. Tamura H Nihon Rinsho; 2015 Jan; 73(1):85-9. PubMed ID: 25626310 [TBL] [Abstract][Full Text] [Related]
12. Initial treatment of transplant candidates with multiple myeloma. Moreau P; Touzeau C Semin Oncol; 2013 Oct; 40(5):585-91. PubMed ID: 24135403 [TBL] [Abstract][Full Text] [Related]
13. Second stem cell transplants for multiple myeloma. If at once you don't succeed, should we really try, try again? Giralt S Biol Blood Marrow Transplant; 2012 May; 18(5):658-9. PubMed ID: 22421242 [No Abstract] [Full Text] [Related]
14. Reversal of severe graft-versus-host disease after nonmyeloablative matched unrelated donor stem cell transplant by infusion of backup autologous peripheral blood stem cells. Khan SA; Moreb JS Bone Marrow Transplant; 2005 Aug; 36(3):267-8. PubMed ID: 15937501 [No Abstract] [Full Text] [Related]
15. Autologous stem-cell transplantation in multiple myeloma. Gahrton G Wien Med Wochenschr; 1995; 145(2-3):52-4. PubMed ID: 7762254 [TBL] [Abstract][Full Text] [Related]
16. New questions about transplantation in multiple myeloma. Hari P; Pasquini MC; Vesole DH Oncology (Williston Park); 2006 Sep; 20(10):1230-42; discussion 1242, 1244, 1249-50. PubMed ID: 17024872 [TBL] [Abstract][Full Text] [Related]
17. Simple variables predict survival after autologous transplantation: a single centre experience in 181 multiple myeloma patients. Krejci M; Hajek R; Buchler T; Krivanova A; Svobodnik A; Pour L; Adam Z; Mayer J; Vorlicek J Neoplasma; 2007; 54(2):143-8. PubMed ID: 17319788 [TBL] [Abstract][Full Text] [Related]
18. Molecular remission of multiple myeloma with cytoreductive autografting followed by a dose-reduced allograft. Fujikawa K; Nakaseko C; Cho R; Abe D; Oda K; Tanaka H; Ohwada C; Ozawa S; Takeuchi M; Sakaida E; Shimizu N; Naito M; Nishimura M; Saito Y Bone Marrow Transplant; 2007 Nov; 40(10):997-9. PubMed ID: 17724437 [No Abstract] [Full Text] [Related]